From ocular immune privilege to primary autoimmune diseases of the eye

After the discovery of ocular immune privilege, exhaustive research has been performed, and advances have been made in the field of ocular immunology. Currently, it is clear that local and systemic pathways are involved in maintaining a well-preserved environment to guarantee normal vision. The deve...

Full description

Saved in:
Bibliographic Details
Published inAutoimmunity reviews Vol. 21; no. 8; p. 103122
Main Authors Nieto-Aristizábal, Ivana, Mera, Juan José, Giraldo, José David, Lopez-Arevalo, Hugo, Tobón, Gabriel J.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2022
Subjects
Eye
CRP
CFH
MRI
RPE
CFI
CNV
TNF
Eye
SC
AMD
ON
IOI
IL
MS
MU
AIR
PIC
BCR
CAR
CFB
MAR
Online AccessGet full text

Cover

Loading…
More Information
Summary:After the discovery of ocular immune privilege, exhaustive research has been performed, and advances have been made in the field of ocular immunology. Currently, it is clear that local and systemic pathways are involved in maintaining a well-preserved environment to guarantee normal vision. The development of autoimmunity in the eye is still a subject of research; however, it has been suggested that microglial cells could act as a gateway for initiating autoimmunity. Moreover, based on the fact that ocular involvement in systemic autoimmune diseases is well described, we aimed to collect and describe ocular diseases with a proposed primary autoimmune pathogenic mechanism. It should be noted that the autoimmune classification in several entities is a topic of discussion among authors. •Immunology of the eye is a complex system involving local and systemic pathways.•The classification of several ocular diseases as autoimmune is subject to debate.•There is a lack of literature revisions on primary autoimmunity in the eye.•We collected ocular diseases with a proposed primary autoimmune pathophysiology.
ISSN:1568-9972
1568-9972
1873-0183
DOI:10.1016/j.autrev.2022.103122